[1] 李长贵. 中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志, 2020,36(1):1-13.
[2] Yu W, Cheng J D.Uric acid and cardiovascular disease: An update from molecular mechanism to clinical perspective[J]. Front Pharmacol, 2020,11:582680.
[3] Yanai H, Adachi H, Hakoshima M, et al.Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease[J]. Int J Mol Sci, 2021,22(17).
[4] Hao Y, Li H, Cao Y, et al.Uricase and horseradish peroxidase hybrid CaHPO4 nanoflower integrated with transcutaneous patches for treatment of hyperuricemia[J]. J Biomed Nanotechnol, 2019,15(5):951-965.
[5] Chen-Xu M, Yokose C, Rai S K, et al.Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: The national health and nutrition examination survey, 2007-2016[J]. Arthritis Rheumatol, 2019,71(6):991-999.
[6] 胡浩杰,苏畅,王惠君,等.2015年中国15省份18~59岁成年居民血清尿酸水平及高尿酸血症患病状况[J]. 中华流行病学杂志, 2021,42(5):840-845.
[7] 林少凯,赖善榕,黄峥,等.福建省居民膳食模式及高尿酸血症影响因素分类树分析[J]. 中国公共卫生, 2018,34(6):798-802.
[8] 陶世冰,任艳,冉兴无,等.四川地区成年人高尿酸血症患病率及相关危险因素的调查性研究[J]. 四川医学, 2018,39(2):133-137.
[9] 储晓天,张昀,邓成艳,等.雌激素与高尿酸血症[J]. 中华临床免疫和变态反应杂志, 2019,13(5):400-405.
[10] 王丹晨,尹逸丛,禹松林,等.北京协和医院2012-2017年体检人群高尿酸血症患病率变化及与血糖、血脂相关性的调查[J]. 临床检验杂志, 2018,36(6):462-466.
[11] 于雪莹, 张铁,曹沁梅,等.中国中老年普通人群血清尿酸水平与血脂谱的关系[J]. 中国老年学杂志, 2019,39(15):3634-3638.
[12] Russo E, Viazzi F, Pontremoli R, et al.Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project[J]. J Nephrol, 2022,35(1):211-221. |
